PMID: 6409240Jul 16, 1983Paper

Adverse reactions during treatment with amiodarone hydrochloride

British Medical Journal
B McGovernJ N Ruskin

Abstract

Amiodarone was administered to 80 patients with recurrent cardiac tachyarrhythmias previously resistant to drug treatment. Forty nine patients were treated for ventricular tachycardia or fibrillation and 31 for supra-ventricular arrhythmias. The mean (range six days to 51 months), permitting a total of 100 patient years of observation. Adverse reactions were observed in 69 patients. Severe side effects were encountered in 13: four patients developed interstitial pneumonitis, four patients developed incessant ventricular tachycardia, three patients taking amiodarone and digoxin sustained sinus node arrest with depression of escape foci, one patient developed hepatitis, and one patient developed hypercalcaemia with renal failure. Furthermore, a rise in the serum concentration of digoxin and potentiation of warfarin anticoagulation occurred in cases in which these agents were combined with amiodarone. Amiodarone was stopped in 14 patients because of side effects. Although amiodarone is effective in suppressing arrhythmias in most patients in whom extensive use of antiarrhythmic drugs has been unsuccessful, it is associated with diverse and serious toxicity. These observations suggest that at present the use of amiodarone should be...Continue Reading

References

Jan 5, 1979·Journal of Neurology·C MeierH P Ludin
Oct 1, 1978·British Heart Journal·A K BrownP Newton
Apr 22, 1976·The New England Journal of Medicine·T L Petty
Jan 1, 1972·Dermatologica·A K VosJ P Goossens
Dec 1, 1970·The Journal of Clinical Investigation·T W Smith, E Haber
Jun 12, 1982·Lancet·R TartiniU A Meyer
Feb 1, 1981·Archives of Ophthalmology·D J D'AmicoJ N Ruskin
Sep 18, 1982·British Medical Journal·R I Reid, M A Ashby
Jan 24, 1981·British Medical Journal·J O MoyseyD A Chamberlain
May 30, 1981·British Medical Journal·A ReesM J Lewis
Jul 4, 1981·British Medical Journal·M J SerlinG J Green
Jan 16, 1982·British Medical Journal·B McGovernJ N Ruskin
Jan 16, 1982·British Medical Journal·S A RileyN J Cooke
May 1, 1982·British Medical Journal·A J Wright, R G Brackenridge
Oct 9, 1982·British Medical Journal·W N Brodine, J DeSantis
May 1, 1982·Circulation·A HamerD Weiss
Oct 1, 1982·Annals of Internal Medicine·D C WestveerG C Timmis
Dec 1, 1982·Annals of Internal Medicine·F E MarchlinskiM E Josephson
Nov 1, 1981·The Journal of Clinical Endocrinology and Metabolism·S MelmedJ M Hershman
Sep 1, 1980·American Heart Journal·H H RotmenschS Laniado

❮ Previous
Next ❯

Citations

Jul 1, 1988·Cardiovascular Drugs and Therapy·N J Linker, A J Camm
Jan 1, 1989·Lung·B D WilsonM L Lippmann
Jun 10, 2008·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Nikolaus A Haas, Christoph K Camphausen
Nov 24, 1983·The New England Journal of Medicine·J N RuskinE Kelly
Dec 3, 1983·British Medical Journal·W J McKennaD M Krikler
Feb 4, 1984·British Medical Journal·D E Ward
Jun 2, 1984·British Medical Journal·P K LimD W Hole
Sep 1, 1986·British Heart Journal·C A BucknallD W Holt
Jun 1, 1988·British Heart Journal·M PyeS M Cobbe
Mar 1, 1985·Postgraduate Medical Journal·A SamantaW W Barrie
May 1, 1987·Postgraduate Medical Journal·P PatelR D Watson
Sep 1, 1992·Postgraduate Medical Journal·L M SamuelI R Starkey
Jul 1, 1994·Postgraduate Medical Journal·R ShuklaJ E Pohl
Jul 5, 2012·World Journal of Hepatology·Mounia LahbabiHafid Aqodad
Nov 14, 2014·CNS Drugs·J van GaalenB P C van de Warrenburg
Jul 1, 1989·Medical Toxicology and Adverse Drug Experience·G V NaccarelliD M Fitzgerald
Jan 1, 1992·Current Medical Research and Opinion·M Sandler
Nov 26, 2010·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Emna El Golli-BennourHassen Bacha
Jun 5, 2001·The American Journal of Medicine·D A Groneberg, A Barkhuizen
Jan 24, 2009·Pharmacoepidemiology and Drug Safety·Lucía LlanosPedro Zapater
Nov 1, 1985·The British Journal of Dermatology·J FergusonW Frain-Bell
Oct 1, 1984·The American Journal of Cardiology·W J McKennaJ F Goodwin
May 15, 2013·The American Journal of Cardiology·Jason LamAnne M Holbrook
Dec 1, 1986·Journal of Pharmacokinetics and Biopharmaceutics·S J Weir, C T Ueda
Nov 20, 2012·Dermatologic Clinics·Mansi PatelRodney Sinclair
Sep 7, 2012·QJM : Monthly Journal of the Association of Physicians·P KorantzopoulosJ A Goudevenos
Sep 28, 2016·Case Reports in Critical Care·Robin PaudelJyoti Matta
Feb 6, 2004·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·Lis Andersen TorpetBirgitte Nauntofte
Jan 15, 1989·Thrombosis Research·C FondevilaM A Lazzari
Jul 1, 1989·Journal of Hepatology·J GenèveD Dhumeaux
May 1, 1985·Clinics in Endocrinology and Metabolism·R L Himsworth
Apr 6, 2004·Clinics in Chest Medicine·Philippe CamusEdward C Rosenow
Feb 25, 1998·Pacing and Clinical Electrophysiology : PACE·M Jafari-Fesharaki, M M Scheinman
Dec 1, 1993·Pacing and Clinical Electrophysiology : PACE·H R HawthorneK A Ellenbogen
May 1, 1989·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J H LewisH J Zimmerman
Nov 1, 1986·Australian and New Zealand Journal of Ophthalmology·G M EckertM D Steiner
Jun 1, 1985·Australian and New Zealand Journal of Medicine·N E AndersonK P O'Brien
Sep 1, 1992·Postgraduate Medical Journal·P J Mullen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.